MS Speaks
Here for 17 years--for people with an interest in multiple sclerosis
Welcome,
Guest
. Please
login
or
register
.
1 Hour
1 Day
1 Week
1 Month
Forever
Login with username, password and session length
This topic
This board
Entire forum
Home
Search
Today's Posts
Contact
Login
Register
MS Speaks 5/06 to 11/13
MS Speaks
»
Forum
»
Multiple Sclerosis
»
TREATMENTS
»
DRUG INFORMATION
»
Message #2298
« previous
next »
Print
Pages: [
1
]
Author
Topic: DRUG INFORMATION (Read 575 times)
0 Members and 1 Guest are viewing this topic.
agate
Administrator
Posts: 9821
MS diagnosed 1980
Location: Pacific Northwest
Promising MS agents in late-stage development
«
on:
December 06, 2018, 08:48:27 am »
This provides a fairly clear brief summary of the currently available MS drugs and the drugs in the pipeline.
Interesting that there are now several drugs for SPMS listed in the pipeline. One of them, masitinib AB is designated for "rfSPMS" (relapse-free secondary progressive MS).
From P&T Community (received December 6, 2018):
https://www.ptcommunity.com/journal/article/full/2018/12/750/promising-multiple-sclerosis-agents-late-stage-development
Report to moderator
Logged
MS Speaks--online for 17 years
SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Print
Pages: [
1
]
« previous
next »
MS Speaks
»
Forum
»
Multiple Sclerosis
»
TREATMENTS
»
DRUG INFORMATION
»
Message #2298